Literature DB >> 27891286

Spontaneous Intramural Duodenal Hematoma: Pancreatitis, Obstructive Jaundice, and Upper Intestinal Obstruction.

Chalerm Eurboonyanun1, Kulyada Somsap2, Somchai Ruangwannasak1, Anan Sripanaskul1.   

Abstract

Nontraumatic intramural duodenal hematoma can cause upper gastrointestinal tract obstruction, upper gastrointestinal hemorrhage, jaundice, and pancreatitis and may be present in patients with normal coagulation. However the pathogenesis of the condition and its relationship with acute pancreatitis remain unknown. We present a case of spontaneous intramural duodenal hematoma and a case of successful nonoperative treatments.

Entities:  

Year:  2016        PMID: 27891286      PMCID: PMC5116499          DOI: 10.1155/2016/5321081

Source DB:  PubMed          Journal:  Case Rep Surg


1. Introduction

Intramural duodenal hematoma was first described by McLauchlan in 1838 [1]. Intramural duodenal hematoma usually occurs secondary to blunt abdominal injury [2, 3]. Spontaneous intramural duodenal hematoma has been associated with coagulopathy, coagulating drugs, and endoscopic procedures [4-8]. However, there are many reports regarding intramural duodenal hematoma's association, with acute pancreatitis and pancreatic malignancy [9-13]. However, the association between intramural duodenal hematoma and acute pancreatitis is still unclear. In this paper, we discuss a case in which a patient presented with obstructive jaundice, upper gastrointestinal obstruction, and upper gastrointestinal hemorrhage complicated by acute pancreatitis.

2. Ethical Consideration

This retrospective case report was approved by the Ethics Committee for Human Research based on the declaration of Helsinki and the ICH good clinical practice guidelines. Clinical data were obtained by reviewing medical records.

3. Case Report

A 27-year-old Thai male was admitted to the hospital after experiencing one day of epigastric pain, hematemesis, and jaundice without evidence of previous trauma. His symptoms also resulted in upper gastrointestinal obstruction, which caused 2 kilograms of weight loss (70 to 68 kilograms) in one week. He had no history of warfarin or aspirin therapy. However, he was a heavy drinker consuming 500 mL of liquor per day. A physical examination revealed jaundice and mild tenderness over the epigastric region. Blood tests showed a hemoglobin level of 12.3 g/dL, white blood cell count of 13,960/μL, platelet count of 669,000/μL, prothrombin time of 12.10 sec, INR of 1.14, activated partial thromboplastin time of 31.40 sec, lipase level of 477 U/L, and total bilirubin level of 12.1 mg/d. Contrast-enhanced abdominal computed tomography revealed hematoma in the whole duodenum with duodenitis. Localized acute pancreatitis was found in the uncinate process and head of the pancreas with a small pancreatic pseudocyst causing distal common bile duct obstruction with biliary dilatation (Figures 1(a)-1(b)).
Figure 1

(a) Noncontrast CT scan shows a heterogeneously high-attenuation mass (∗) along the course of 1st, 2nd, and 3rd part of duodenum, which is compatible with duodenal hematoma. Note the surrounding fat stranding. S = stomach. (b) Contrast-enhanced CT shows the lack of enhancement within the mass (asterisk). Note the displacement of gas in gastric lumen secondary to mass.

Esophagogastroduodenoscopy showed bulging, inflammation, and swelling of mucosa at the posterolateral wall of second to third part of the duodenum with partial obstruction of the duodenal lumen (Figure 2). Endoscopic ultrasonography showed a heteroechoic mass at the posterolateral wall of the duodenum (Figure 3).
Figure 2

Submucosal swelling with erythematous surface extending from the duodenal bulb to the 3rd part of the duodenum causing partial duodenal obstruction: suspected intramural duodenal hematoma.

Figure 3

Endoscopic ultrasonography revealed avascular a heteroechoic submucosal mass at the posterolateral wall of the duodenum.

The patient was diagnosed with acute pancreatitis, intramural duodenal hematoma, acute cholangitis, and upper gastrointestinal obstruction. He was conservatively treated with intravenous antibiotics and fluid replacement therapy, restricting the oral intake of food/liquids. 17 days after admission the patient was able to consume a low residual diet orally without abdominal discomfort. His jaundice had also improved. He discontinued intravenous antibiotics after 10 days of therapy. He was discharged on the 21st day after admission. Three months after admission follow-up esophagogastroduodenoscopy showed normal duodenal mucosa with a mild narrowing of the lumen at the second part of the duodenum. Magnetic resonance cholangiopancreatography revealed a distal common bile duct obstruction and revealed that the intramural duodenal hematoma, pancreatitis of head, and uncinate process had resolved (Figures 4(a)-4(b)).
Figure 4

A follow-up MRI after 3 months of conservative treatment shows a nearly complete resolution of the duodenal hematoma.

4. Discussion

Spontaneous intramural duodenal hematoma is usually associated with coagulation abnormalities resulting from anticoagulating drugs [4-7]. If spontaneous intramural duodenal hematoma occurs in patients with normal coagulation, pancreatic diseases should be investigated [9-14]. In cases of spontaneous intramural small bowel hematoma, the rates of abdominal pain and emesis are high (84.6–100%). However, hematemesis and fever are only occasionally present (15.3–23.1%) [6]. In this case, the patient presented with abdominal pain, hematemesis, and jaundice. The only positive findings upon physical examination were jaundice and mild tenderness over the epigastric region. CT scans, gastroduodenoscopy, and endoscopic ultrasonography revealed evidence of duodenal hematoma, pancreatitis, biliary obstruction, and a gallstone. He was successfully treated using conservative methods. Although there has been a case report of endoscopic decompression for intramural duodenal hematoma with gastric outlet obstruction to relieve the symptoms of the obstruction [15], this procedure requires further investigation. In this case, the disease may have developed from either alcoholic pancreatitis due to patient's history of heavy drinking or biliary pancreatitis, as there was evidence of a gallstone. It is also possible that spontaneous intramural duodenal hematoma of unknown origin caused the acute pancreatitis. But pancreatitis is likely to be the leading cause in this case, based on the patient's history of alcohol consumption and evidence of a gallstone without any coagulation abnormalities. However, it is difficult to explain the true pathophysiology. In conclusion, the patient who presented with spontaneous intramural duodenal hematoma with acute pancreatitis with clinical jaundice, upper gastrointestinal obstruction, and upper gastrointestinal hemorrhage was able to be treated conservatively. However, the relationship between the disease and pathophysiology remains unclear.
  14 in total

1.  Acute pancreatitis with an intramural duodenal hematoma.

Authors:  Chia-Ming Chang; Hsien-Hao Huang; Chorng-Kuang How
Journal:  Intern Med       Date:  2015-04-01       Impact factor: 1.271

2.  Acute pancreatitis associated with a nontraumatic, intramural duodenal hematoma.

Authors:  N Veloso; P Amaro; M Ferreira; J M Romãozinho; C Sofia
Journal:  Endoscopy       Date:  2013-03-22       Impact factor: 10.093

3.  Spontaneous intramural small-bowel hematoma: clinical presentation and long-term outcome.

Authors:  Maher A Abbas; Joseph M Collins; Kevin W Olden; Keith A Kelly
Journal:  Arch Surg       Date:  2002-03

4.  Intramural hematoma of the duodenum: a review of the literature and case report.

Authors:  W R Jones; W J Hardin; J T Davis; J D Hardy
Journal:  Ann Surg       Date:  1971-04       Impact factor: 12.969

5.  Successful endoscopic decompression for intramural duodenal hematoma with gastric outlet obstruction complicating acute pancreatitis.

Authors:  Jun Young Lee; Jin Soo Chung; Tae Hyeon Kim
Journal:  Clin Endosc       Date:  2012-08-22

6.  Spontaneous intramural small-bowel hematoma: imaging findings and outcome.

Authors:  Maher A Abbas; Joseph M Collins; Kevin W Olden
Journal:  AJR Am J Roentgenol       Date:  2002-12       Impact factor: 3.959

7.  Acute pancreatitis secondary to intramural duodenal hematoma: Case report and literature review.

Authors:  Kazue Shiozawa; Manabu Watanabe; Yoshinori Igarashi; Yasushi Matsukiyo; Teppei Matsui; Yasukiyo Sumino
Journal:  World J Radiol       Date:  2010-07-28

8.  Anticoagulant-induced intramural intestinal hemorrhage.

Authors:  Chia-Ying Tseng; Ju-Sing Fan; Shu-Chuan Yang; Hsien-Hao Huang; Jen-Dar Chen; David Hung-Tsang Yen; Chun-I Huang
Journal:  Am J Emerg Med       Date:  2010-03-09       Impact factor: 2.469

9.  Ultrasound and CT diagnosis of intramural duodenal hematoma.

Authors:  K Hayashi; S Futagawa; S Kozaki; K Hirao; Z Hombo
Journal:  Pediatr Radiol       Date:  1988

10.  Intramural hematoma of the duodenum.

Authors:  T C Jewett; V Caldarola; M P Karp; J E Allen; D R Cooney
Journal:  Arch Surg       Date:  1988-01
View more
  4 in total

1.  Intramural Duodenal Hematoma Secondary to Necrotizing Pancreatitis Leading to Gastric Outlet Obstruction.

Authors:  Aarati Keshary; Layth Al Attar; Eric P Lembke; William J Salyers
Journal:  Kans J Med       Date:  2022-05-17

2.  Endoscopic management of intramural spontaneous duodenal hematoma: A case report.

Authors:  Giorgio Valerii; Vittorio Maria Ormando; Carlo Cellini; Luca Sacco; Carmelo Barbera
Journal:  World J Gastroenterol       Date:  2022-05-28       Impact factor: 5.374

3.  A case of spontaneous intramural duodenal hematoma in a young African man: Imaging findings.

Authors:  Adu Tutu Amankwa; Esi De Graft-Johnson; Kwasi Adjepong Twum; Kwasi Ankomah
Journal:  Radiol Case Rep       Date:  2021-04-30

4.  Acute pancreatitis secondary to spontaneous intramural duodenal hematoma: A case report and a review of the literature.

Authors:  Wissal Skhiri; Marwa Moussaoui; Jamal Saad; Mohamed Maatouk; Asma Chaouch; Ines Mazhoud
Journal:  Int J Surg Case Rep       Date:  2022-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.